Edition:
United Kingdom

Emergent BioSolutions Inc (EBS.N)

EBS.N on New York Stock Exchange

52.81USD
23 Apr 2019
Change (% chg)

$0.58 (+1.11%)
Prev Close
$52.23
Open
$52.25
Day's High
$53.13
Day's Low
$52.12
Volume
103,040
Avg. Vol
146,591
52-wk High
$73.83
52-wk Low
$46.93

Select another date:

Mon, Nov 19 2018

Emergent-Valneva Zika vaccine clears early trial

A vaccine to prevent infections caused by the deadly mosquito-borne Zika virus induced immune response and was found to be safe in an early stage trial, Emergent BioSolutions Inc and partner Valneva SE said on Monday.

Emergent-Valneva Zika vaccine clears early trial

Nov 19 A vaccine to prevent infections caused by the deadly mosquito-borne Zika virus induced immune response and was found to be safe in an early stage trial, Emergent BioSolutions Inc and partner Valneva SE said on Monday.

Select another date: